Propofol versus thiopental sodium for the treatment of refractory status epilepticus

Cochrane Database of Systematic Reviews

Volumn 2015, Issue 6, 2015, Pages

  Prabhakar, Hemanshu ^a   Kalaivani, Mani ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

[No Author keywords available]

Indexed keywords

PROPOFOL; THIOPENTAL; ANTICONVULSIVE AGENT; INTRAVENOUS ANESTHETIC AGENT;

ADVERSE EVENT; AGE; DRUG EFFICACY; DRUG SAFETY; EPILEPTIC STATE; GENDER; HOSPITAL MORTALITY; HUMAN; HYPOTENSION; INFECTION; INTENSIVE CARE UNIT; LENGTH OF STAY; META ANALYSIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SEIZURE; SYSTEMATIC REVIEW; TREATMENT OUTCOME; ADULT; ARTIFICIAL VENTILATION; DRUG RESISTANT EPILEPSY; STATUS EPILEPTICUS;

ADULT; ANESTHETICS, INTRAVENOUS; ANTICONVULSANTS; DRUG RESISTANT EPILEPSY; HUMANS; PROPOFOL; RESPIRATION, ARTIFICIAL; STATUS EPILEPTICUS; THIOPENTAL;

EID: 84957792963     PISSN: None     EISSN: 1469493X     Source Type: Journal    
DOI: 10.1002/14651858.CD009202.pub3     Document Type: Review

References (21)

1. Rossetti AO, Milligan TA, Vulliemoz S, Michaelides C, Bertschi M, Lee JW. A randomized trial for the treatment of refractory status epilepticus. Neurocritical Care 2011;14(1):4-10. [DOI: 10.1007/s12028-010-9445-z]
2. Claassen J, Hirsch LJ, Emerson RG, Mayer SA. Treatment of refractory status epilepticus with pentobarbital, propofol, or midazolam: a systematic review. Epilepsia 2002;43(2):146-53. [PUBMED: 11903460 ]
3. Higgins JPT, Thompson SG. Quantifying heterogeneity in a meta-analysis. Statistics in Medicine 2002;21(11):1539-58. [PUBMED: 12111919]
4. Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from http://handbook.cochrane.org/.
5. Holtkamp M. The anaesthetic and intensive care of status epilepticus. Current Opinion in Neurology 2007;20(2):188-93. [PUBMED: 17351490 ]
6. Lefebvre C, Manheimer E, Glanville J. Chapter 6: Searching for studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from http://handbook.cochrane.org/.
7. Marik PE. Propofol: therapeutic indications and side effects. Current Pharmaceutical Design 2004;10(29):3639-49. [PUBMED: 15579060 ]
8. Mayer SA, Claasen J, Lokin J, Mendelsohn F, Dennis LJ, Fitzsimmons BF. Refractory status epilepticus: frequency, risk factors, and impact on outcome. Archives of Neurology 2002;59(2):205-10. [PUBMED: 11843690 ]
9. Parviainen I, Uusaro A, Kalviainen R, Kaukanen E, Mervaala E, Ruokonen E. High-dose thiopental in the treatment of refractory status epilepticus in intensive care unit. Neurology 2002;59(8):1249-51. [PUBMED: 12391357 ]
10. Prasad K, Al-Roomi K, Krishnan PR, Sequeira R. Anticonvulsant therapy for status epilepticus. Cochrane Database of Systematic Reviews 2005, Issue 4. [DOI: 10.1002/14651858.CD003723.pub2]
11. The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014.
12. Rogowski MA, Loscher W. The neurobiology of antiepileptic drugs. Nature Reviews Neuroscience 2004;5(7):553-64. [PUBMED: 15208697 ]
13. Rossetti AO, Logroscino G, Bromfield EB. Refractory status epilepticus. Effects of treatment aggressiveness on prognosis. Archives of Neurology 2005;62(11):1698-702. [PUBMED: 16286542 ]
14. Rossetti AO. Which anesthetic should be used in the treatment of refractory status epilepticus?. Epilepsia 2007;48(Suppl 8):52-5. [PUBMED: 18330000 ]
15. Treiman DM, Meyers PD, Walton NY, Colling C, Rowan AJ, Handforth A, et al. A comparison of four treatments for generalized convulsive status epilepticus: Veterans Affairs Status Epilepticus Cooperative Study Group. New England Journal of Medicine 1998;339(12):792-8. [PUBMED: 9738086]
16. Van Gestel JP, Blussé van Oud-Alblas HJ, Malingré M, Ververs FF, Braun KP, Van Nieuwenhuizen O. Propofol and thiopental for refractory status epilepticus in children. Neurology 2005;65(4):591-2. [PUBMED: 16116121 ]
17. Treatment of convulsive status epilepticus. Recommendations of the Epilepsy Foundation of America's Working Group on Status Epilepticus. JAMA 1993;270(7):854-9. [PUBMED: 8340986 ]
18. Zarovnaya EL, Jobst BC, Harris BT. Propofol-associated fatal myocardial failure and rhabdomyolysis in an adult with status epilepticus. Epilepsia 2007;48(5):1002-6. [PUBMED: 17381434 ]
19. Zhan RZ, Qi S, Wu C, Fujihara H, Taga K, Shimoji K. Intravenous anaesthetics differentially reduce neurotransmission damage caused by oxygen-glucose deprivation in rat hippocampal slices in correlation with N-methyl-D-aspartate receptor inhibition. Critical Care Medicine 2001;29(4):808-13. [PUBMED: 11373474 ]
20. Prabhakar H, Bindra A, Singh GP, Kalaivani M. Propofol versus thiopental sodium for the treatment of refractory status epilepticus. Cochrane Database of Systematic Reviews 2011, Issue 7. [DOI: 10.1002/14651858.CD009202.pub2]
21. Prabhakar H, Bindra A, Singh GP, Kalaivani M. Propofol versus thiopental sodium for the treatment of refractory status epilepticus. Cochrane Database of Systematic Reviews 2012, Issue 8. [DOI: 10.1002/14651858.CD009202.pub2]